Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. - Baiyunshan Hanfang
You are now at:Blog > Article Content

Guangzhou Baiyunshan Hanfang Launches Highly Controllable Injectable Soybean Oil

Time:2026-08-12

Domestic Manufacturer Delivers Stable, Globally Compliant Injectable-Grade Raw Material for Pharma Industry

GUANGZHOU, China – 2026 – Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd., a leading provider of high-end pharmaceutical lipid excipients and health products, today announces the launch of its highly controllable injectable soybean oil. This new product addresses the core pain point of unstable domestic supply of injectable-grade excipients for pharmaceutical enterprises, featuring strict quality control, consistent purity, and compliance with international regulatory standards. The product is now available for global pre-orders, with mass production and shipping already underway.

Core Technical Breakthroughs & Product Highlights

First, the injectable soybean oil achieves exceptional purity through an integrated green production process combining supercritical CO₂ extraction, membrane separation, and chromatographic separation, replacing traditional high-pollution methods to ensure consistent quality and minimal impurities. Second, its highly controllable fatty acid composition provides stable performance for formulating high-end injectable emulsions and lipid-based drug delivery systems, helping pharmaceutical manufacturers maintain production consistency. Third, it serves as a reliable energy supplement and pharmaceutical excipient, catering to the needs of high-end injectable drug producers worldwide.

Global Compliance & Certifications

To meet global market access requirements, the injectable soybean oil complies with international pharmaceutical standards and holds key certifications including EU CEP, US FDA US-DMF, Mexico Cofepris, and India DCGI. It meets regulatory requirements in major markets across Europe, North America, and Asia-Pacific, supporting widespread application in global pharmaceutical production.

Supply & Customization Services

The highly controllable injectable soybean oil is available for global pre-orders via the official website (http://byshanhanfang.com/) and authorized distributors. Mass production and global shipping have commenced immediately. Beyond standard products, the company offers customized services for enterprise clients, including tailored fatty acid composition adjustments and packaging solutions to meet diverse industry needs.

Authoritative Quotes

"The launch of our injectable soybean oil marks another milestone in breaking international monopolies and securing domestic supply of high-end pharmaceutical excipients," said Xu Wendong, General Manager and Deputy Director of the National Engineering Research Center at Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. "We are committed to delivering globally compliant, reliable raw materials to support pharmaceutical enterprises worldwide."

"As a long-term partner, we trust Hanfang's technical innovation and quality control," noted a representative from B. Braun Company. "This new product will enhance our production stability and help meet growing demand for high-quality injectable drugs.

Industry Context & Strategic Alignment

Industry reports project steady growth in the global injectable excipients market, driven by rising demand for high-end injectable drugs and biopharmaceuticals. Hanfang’s launch aligns with its strategy to expand global market presence and provide localized solutions for pharmaceutical clients.

Company Profile

Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd., founded in 1998, is a core enterprise under Guangzhou Pharmaceutical Holdings Group. It is a national-level specialized, sophisticated, unique, and new "Little Giant" enterprise, housing the only national engineering research center for traditional Chinese medicine pharmaceutical process technology. The company serves over 1,000 clients in more than 30 countries, including AstraZeneca and Sichuan Kelun Pharmaceutical, with a mission to achieve technological self-reliance and ensure pharmaceutical industry chain security.

For more information, visit http://byshanhanfang.com/.

Contact Information

Company: Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.
Official Website: http://byshanhanfang.com/

© 2026 Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. All rights reserved.

Copyright Copyright Notice:Baiyunshan Hanfang
Related Articles

Guess You Like